인공 고관절 치환술 시장 : 규모, 점유율, 성장, 세계 산업 분석, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of hip replacement Market

The global hip replacement market is experiencing steady growth due to the rising prevalence of osteoarthritis, increasing geriatric population, and growing adoption of technologically advanced orthopedic implants. According to the report, the global hip replacement market size was valued at USD 8.40 billion in 2025 and is projected to grow from USD 8.80 billion in 2026 to USD 13.76 billion by 2034, exhibiting a CAGR of 5.75% during the forecast period. North America dominated the global market with a 34.46% market share in 2025, supported by a high volume of hip arthroplasty procedures, favorable reimbursement policies, and continuous product innovation.

Hip replacement surgery is a widely performed orthopedic procedure in which damaged hip joints are replaced with artificial implants to relieve pain, restore mobility, and improve quality of life. The procedure is primarily recommended for patients suffering from severe osteoarthritis, hip fractures, rheumatoid arthritis, and other degenerative joint disorders that limit daily activities.

Market Definition and Scope

Hip replacement involves replacing damaged portions of the hip joint with artificial prosthetic implants made from metal, ceramic, or polyethylene materials. The procedure includes total hip replacement, partial hip replacement, revision surgery, and hip resurfacing, depending on the patient's medical condition and severity of joint damage.

The market covers hip implants, robotic-assisted surgical systems, customized prostheses, navigation technologies, and orthopedic surgical services used across hospitals, ambulatory surgery centers (ASCs), orthopedic clinics, and specialty healthcare facilities. Continuous technological advancements, including robotic surgery, 3D printing, and patient-specific implants, are expanding the scope of the global hip replacement market.

Market Dynamics

Drivers

The increasing prevalence of osteoarthritis remains the primary factor driving market growth. Aging populations worldwide are more susceptible to degenerative joint diseases, creating a large patient pool requiring hip replacement procedures. Rising awareness regarding available treatment options and improved diagnosis rates are further increasing the number of surgeries performed globally.

Another major growth driver is the growing adoption of customized hip implants and robotic-assisted surgical procedures. Manufacturers are increasingly utilizing advanced technologies such as 3D printing and computer-assisted navigation to develop patient-specific implants that improve surgical precision, implant longevity, and recovery outcomes.

Trends

A significant trend shaping the market is the increasing use of digital healthcare tools and robotic-assisted hip replacement surgery. Hospitals and healthcare providers are adopting advanced robotic platforms and navigation systems to enhance surgical accuracy and improve patient outcomes.

Another emerging trend is the growing availability of online patient education platforms and mobile applications that support patients before and after surgery. These digital resources improve patient engagement, rehabilitation, and long-term recovery following hip replacement procedures.

Restraints

Despite strong market growth, product recalls and lawsuits associated with orthopedic implants remain major challenges. Device failures, implant wear, infections, allergic reactions, and metal-related complications have resulted in several legal cases against major manufacturers, affecting market confidence.

Additionally, stringent regulatory requirements and product recalls increase compliance costs and may delay the introduction of new implant technologies into the market.

Impact of COVID-19

The COVID-19 pandemic negatively affected the hip replacement market during 2020 due to the postponement of elective and non-emergency orthopedic surgeries. Hospitals prioritized emergency care, leading to a temporary decline in procedural volumes and implant demand. However, following the easing of lockdown restrictions, the backlog of delayed surgeries and increasing patient demand contributed to strong market recovery during 2021 and subsequent years.

Segmentation Analysis

By procedure, the Total Hip Replacement segment is expected to dominate the market with a 73.86% share in 2026, driven by the increasing number of total hip arthroplasty procedures worldwide and growing adoption of robotic-assisted surgery. Partial hip replacement and revision procedures are also witnessing steady growth due to rising osteoarthritis prevalence and increasing demand for revision implants.

By end-user, the Hospitals & Ambulatory Surgery Centers (ASCs) segment is projected to account for 72.96% of the market in 2026. Growth is supported by increasing surgical volumes, favorable reimbursement policies, and rapid adoption of advanced robotic technologies. Orthopedic clinics are also expected to register significant growth due to increasing patient visits for joint disorders and specialized orthopedic care.

Regional Insights

North America dominated the global hip replacement market with a valuation of USD 2.90 billion in 2025, which is projected to reach USD 3.04 billion in 2026. The region benefits from favorable reimbursement policies, high surgical volumes, advanced healthcare infrastructure, and continuous innovation in robotic-assisted orthopedic procedures.

Europe represents the second-largest regional market, valued at USD 2.18 billion in 2025 and projected to reach USD 2.27 billion in 2026, driven by increasing hip replacement procedures, strong reimbursement systems, and growing demand for customized implants. Asia Pacific is expected to witness the fastest growth due to expanding healthcare infrastructure, increasing elderly population, and growing awareness of advanced orthopedic treatments across China, Japan, and India. Latin America and the Middle East & Africa are also experiencing gradual growth supported by improving healthcare access, increasing orthopedic disease prevalence, and rising adoption of hip implants.

Competitive Landscape

The global hip replacement market is highly competitive, with leading manufacturers focusing on technological innovation, robotic-assisted surgery, customized implant development, and strategic collaborations to strengthen their market positions. Companies continue investing heavily in research and development to introduce advanced orthopedic implant systems and improve surgical outcomes.

Major companies operating in the market include Zimmer Biomet, Medical Device Business Services, Inc. (Johnson & Johnson Services, Inc.), Smith+Nephew, Stryker, Exactech Inc., Gruppo Bioimpianti s.r.l., Conformis, MicroPort Scientific Corporation, and B. Braun SE.

Report Coverage

This report provides a comprehensive analysis of the global hip replacement market, covering market size for 2025, 2026, and 2034, key growth drivers, emerging trends, restraints, COVID-19 impact, segmentation by procedure and end-user, regional insights, competitive landscape, reimbursement policies, regulatory environment, and recent industry developments. The report also evaluates technological innovations, robotic surgery advancements, and customized implant developments shaping the future of the orthopedic industry.

Conclusion

The global hip replacement market is projected to grow from USD 8.40 billion in 2025 to USD 13.76 billion by 2034, driven by the increasing prevalence of osteoarthritis, rising geriatric population, expanding adoption of robotic-assisted surgery, and continuous innovation in customized orthopedic implants. Although product recalls and regulatory challenges remain concerns, favorable reimbursement policies, technological advancements, and growing patient awareness will continue to support long-term market growth across developed and emerging healthcare markets.

Segmentation By Procedure

• Total
• Partial
• Revision & Hip Resurfacing

By End-user

• Hospitals & ASCs
• Orthopedic Clinics
• Others

By Geography

• North America (By Procedure, End-user, and Country)
  • U.S. (By Procedure)
  • Canada (By Procedure)
• Europe (By Procedure, End-user, and Country/Sub-region)
  • U.K. (By Procedure)
  • Germany (By Procedure)
  • France (By Procedure)
  • Italy (By Procedure)
  • Spain (By Procedure)
  • Scandinavia (By Procedure)
  • Rest of Europe (By Procedure)
• Asia Pacific (By Procedure, End-user, and Country/Sub-region)
  • China (By Procedure)
  • Japan (By Procedure)
  • India (By Procedure)
  • Australia (By Procedure)
  • Southeast Asia (By Procedure)
  • Rest of Asia Pacific (By Procedure)
• Latin America (By Procedure, End-user, and Country/Sub-region)
  • Brazil (By Procedure)
  • Mexico (By Procedure)
  • Rest of Latin America (By Procedure)
• Middle East & Africa (By Procedure, End-user, and Country/Sub-region)
  • GCC (By Procedure)
  • South Africa (By Procedure)
  • Rest of Middle East & Africa (By Procedure)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Number of Hip Replacement Procedures - by Key Countries, 2025
• 4.2. Regulatory Scenario - by Key Countries/Regions
• 4.3. Reimbursement Scenario - by Key Countries/Regions
• 4.4. Technological Advancements in Hip Replacement Market
• 4.5. Key Industry Developments (Mergers, Acquisitions, New Product Launches, etc.)
• 4.6. Impact of COVID-19 on the Market

5. Global Hip Replacement Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Procedure
  • 5.1.1. Total
  • 5.1.2. Partial
  • 5.1.3. Revision & Hip Resurfacing
• 5.2. Market Analysis, Insights and Forecast - By End-user
  • 5.2.1. Hospitals & ASCs
  • 5.2.2. Orthopedic Clinics
  • 5.2.3. Others
• 5.3. Market Analysis, Insights and Forecast - By Region
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. Asia Pacific
  • 5.3.4. Latin America
  • 5.3.5. Middle East & Africa

6. North America Hip Replacement Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Procedure
  • 6.1.1. Total
  • 6.1.2. Partial
  • 6.1.3. Revision & Hip Resurfacing
• 6.2. Market Analysis, Insights and Forecast - By End-user
  • 6.2.1. Hospitals & ASCs
  • 6.2.2. Orthopedic Clinics
  • 6.2.3. Others
• 6.3. Market Analysis, Insights and Forecast - By Country
  • 6.3.1. U.S.
    • 6.3.1.1. By Procedure
  • 6.3.2. Canada
    • 6.3.2.1. By Procedure

7. Europe Hip Replacement Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Procedure
  • 7.1.1. Total
  • 7.1.2. Partial
  • 7.1.3. Revision & Hip Resurfacing
• 7.2. Market Analysis, Insights and Forecast - By End-user
  • 7.2.1. Hospitals & ASCs
  • 7.2.2. Orthopedic Clinics
  • 7.2.3. Others
• 7.3. Market Analysis, Insights and Forecast - By Countries/ Sub-region
  • 7.3.1. U.K.
    • 7.3.1.1. By Procedure
  • 7.3.2. Germany
    • 7.3.2.1. By Procedure
  • 7.3.3. France
    • 7.3.3.1. By Procedure
  • 7.3.4. Spain
    • 7.3.4.1. By Procedure
  • 7.3.5. Italy
    • 7.3.5.1. By Procedure
  • 7.3.6. Scandinavia
    • 7.3.6.1. By Procedure
  • 7.3.7. Rest of Europe
    • 7.3.7.1. By Procedure

8. Asia Pacific Hip Replacement Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Procedure
  • 8.1.1. Total
  • 8.1.2. Partial
  • 8.1.3. Revision & Hip Resurfacing
• 8.2. Market Analysis, Insights and Forecast - By End-user
  • 8.2.1. Hospitals & ASCs
  • 8.2.2. Orthopedic Clinics
  • 8.2.3. Others
• 8.3. Market Analysis, Insights and Forecast - By Countries/ Sub-region
  • 8.3.1. Japan
    • 8.3.1.1. By Procedure
  • 8.3.2. China
    • 8.3.2.1. By Procedure
  • 8.3.3. India
    • 8.3.3.1. By Procedure
  • 8.3.4. Australia
    • 8.3.4.1. By Procedure
  • 8.3.5. Southeast Asia
    • 8.3.5.1. By Procedure
  • 8.3.6. Rest of Asia Pacific
    • 8.3.6.1. By Procedure

9. Latin America Hip Replacement Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Procedure
  • 9.1.1. Total
  • 9.1.2. Partial
  • 9.1.3. Revision & Hip Resurfacing
• 9.2. Market Analysis, Insights and Forecast - By End-user
  • 9.2.1. Hospitals & ASCs
  • 9.2.2. Orthopedic Clinics
  • 9.2.3. Others
• 9.3. Market Analysis, Insights and Forecast - By Countries/ Sub regions
  • 9.3.1. Brazil
    • 9.3.1.1. By Procedure
  • 9.3.2. Mexico
    • 9.3.2.1. By Procedure
  • 9.3.3. Rest of Latin America
    • 9.3.3.1. By Procedure

10. Middle East & Africa Hip Replacement Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Procedure
  • 10.1.1. Total
  • 10.1.2. Partial
  • 10.1.3. Revision & Hip Resurfacing
• 10.2. Market Analysis, Insights and Forecast - By End-user
  • 10.2.1. Hospitals & ASCs
  • 10.2.2. Orthopedic Clinics
  • 10.2.3. Others
• 10.3. Market Analysis, Insights and Forecast - By Countries/ Sub region
  • 10.3.1. South Africa
    • 10.3.1.1. By Procedure
  • 10.3.2. GCC
    • 10.3.2.1. By Procedure
  • 10.3.3. Rest of Middle East & Africa
    • 10.3.3.1. By Procedure

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Zimmer Biomet
    • 11.2.1.1. Overview
    • 11.2.1.2. Products & Services
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. Medical Device Business Services, Inc. (Johnson & Johnson Services, Inc.)
    • 11.2.2.1. Overview
    • 11.2.2.2. Products & Services
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. Smith+Nephew
    • 11.2.3.1. Overview
    • 11.2.3.2. Products & Services
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. Stryker
    • 11.2.4.1. Overview
    • 11.2.4.2. Products & Services
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. Exactech, Inc.
    • 11.2.5.1. Overview
    • 11.2.5.2. Products & Services
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. Gruppo Bioimpianti s.r.l.
    • 11.2.6.1. Overview
    • 11.2.6.2. Products & Services
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. Conformis
    • 11.2.7.1. Overview
    • 11.2.7.2. Products & Services
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. MicroPort Scientific Corporation
    • 11.2.8.1. Overview
    • 11.2.8.2. Products & Services
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)
  • 11.2.9. B. Braun SE
    • 11.2.9.1. Overview
    • 11.2.9.2. Products & Services
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. Financials (Based on Availability)